Results 71 to 80 of about 1,641,615 (299)

Membrane composition and thermodynamic identity as boundaries of life for synthetic cell research

open access: yesFEBS Letters, EarlyView.
What makes a cell a cell? The boundary of a living cell is not just a wall. Read as a Markov blanket, the membrane separates internal from external states, generating identity and non‐equilibrium order. Can this identity be rebuilt from scratch in a synthetic cell?
Caterina Presutti, Bert Poolman
wiley   +1 more source

All-solution processed CuGaS2-based photoelectrodes for CO2 reduction

open access: yes, 2022
Considering the influence of carbon dioxide (CO2) on global warming, an all-solution approach is presented here to fabricate nanocrystalline film of the ternary chalcopyrite for the photoelectrochemical CO2 reduction.
Brito, Juliana Ferreira de   +7 more
core   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

Phase-tuned performance of Ni-Ru supported molybdenum carbide catalysts for biomass and CO2 conversion

open access: yesMaterials Today Catalysis
With atmospheric CO2 levels persistently rising, CO2 management innovation is transitioning from strategic importance to operational urgency. This study investigates catalytic strategies for CO2 management through biomass CO2 gasification and reverse ...
Shiyu Zhang   +6 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Aerosol emissions and mitigation of aqueous AMP/PZ solvent for postcombustion CO2 capture

open access: yesCarbon Capture Science & Technology
Aerosol emissions from the CO2-capture process have a significant impact on both solvent depletion and environmental contamination. This work comprehensively investigated the emissions of AMP (2-amino-2-methyl-1propanol)/PZ (piperazine) from a bench ...
Lianbo Liu   +4 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

A new LED-LED portable CO2 gas sensor based on an interchangeable membrane system for industrial applications [PDF]

open access: yes, 2011
CO2 monitoring is important for many areas of high economic relevance, like environmental monitoring, control of biotechnological processes in bio-pharmaceutical industries, and the food industry, particularly controlled atmosphere storage rooms and ...
Vargas-Sansalvador, Isabel María Pérez de   +15 more
core   +4 more sources

Research progress of CO2 capture, utilization and storage technology

open access: yesMeitan xuebao
With the extensive use of fossil fuels, the concentration of CO2 in the atmosphere continues to rise, exacerbating the issue of global climate warming.
Yinan ZHANG   +4 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy